carbamazepine has been researched along with Absence Status in 66 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated the anticonvulsant and neuroprotective effects of carbamazepine (CBZ), levetiracetam (LEV), and CBZ + LEV adjunctive treatment in convulsive status epilepticus (CSE) rat model." | 8.02 | Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: Inhibition of cholinergic transmission. ( Abdulwahab, UF; Adedokun, KI; Adekomi, AD; Akanji, NO; Olayiwola, G; Osuntokun, OS, 2021) |
| " In this study, we examined the effects of LEV on neuroinflammation and phagocytic microglia in vivo and in vitro and compared the effects of LEV with those of representative antiepileptic drugs valproate (VPA) and carbamazepine (CBZ)." | 7.91 | Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine. ( Ishihara, Y; Itoh, K; Matsuo, T; Oguro, A; Taniguchi, R; Vogel, CFA; Yamazaki, T, 2019) |
| "Carbamazepine (CBZ) is the gold standard antiepileptic drug (AED) for focal onset seizures." | 7.80 | Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus. ( Beran, RG; Cordato, DJ; Malkan, A; Patel, V, 2014) |
| "Cell damage and spatial localization deficits are often reported as long-term consequences of pilocarpine-induced status epilepticus." | 7.75 | Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus. ( Cunha, AO; dos Santos, WF; Liberato, JL; Mortari, MR, 2009) |
| " Following pilocarpine-induced status epilepticus interrupted after 4h, rats were continuously videorecorded for onset and recurrence of spontaneous convulsive seizures." | 7.73 | Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat. ( Bentivoglio, M; Chakir, A; Fabene, PF; Ouazzani, R, 2006) |
| " We describe two patients with idiopathic generalized epilepsy in whom nonconvulsive status epilepticus, aggravated by carbamazepine, was misdiagnosed as psychiatric disorder." | 7.73 | Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. ( D'Arcangelo, G; Guerrini, R; Marini, C; Masi, G; Parmeggiani, L, 2005) |
| "We investigated the effects of valproate (VPA) on an in vivo model of status epilepticus (SE) induced by intrahippocampal application of 4-aminopyridine (4-AP)." | 7.72 | Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. ( Martín, ED; Pozo, MA, 2003) |
| "We report two patients who experienced status epilepticus after carbamazepine overdose." | 7.71 | Status epilepticus after massive carbamazepine overdose. ( Carlisle, RD; Spiller, HA, 2002) |
| "We report a 14-year-old girl with carbamazepine intoxication who developed alpha coma and status epilepticus." | 7.71 | [A case of carbamazepine intoxication with alpha coma and status epilepticus]. ( Komatsu, K; Ono, A; Sawaishi, Y; Takada, G; Yano, T, 2001) |
| "To compare the frequency of seizures and status epilepticus and their response to first-line drugs in patients with idiopathic generalized epilepsies receiving carbamazepine or phenytoin to those receiving other drugs or no treatment." | 7.70 | Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine. ( Osorio, I; Peltzer, JN; Reed, RC, 2000) |
| " It was proposed that the late activity is a model for pharmacoresistant status epilepticus since it was also refractory to phenytoin, carbamazepine, phenobarbital, and midazolam." | 7.70 | Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. ( Dreier, JP; Heinemann, U; Zhang, CL, 1998) |
| "Effect of adenosinergic agents were investigated in lithium-pilocarpine-induced status epilepticus (SE) in rats." | 7.69 | Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents. ( George, B; Kulkarni, SK, 1997) |
| "The present study compares the efficacy of carbamazepine (20 mg/kg/day) and vigabatrin (250 mg/kg/day) in preventing hippocampal and amygdaloid damage in the perforant pathway stimulation model of status epilepticus in the rat." | 7.69 | Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala. ( Halonen, T; Pitkänen, A; Tuunanen, J, 1996) |
| "We describe an adolescent epileptic patient who presented in nonconvulsive status epilepticus that appeared to be related to treatment with carbamazepine." | 7.68 | Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. ( Callahan, DJ; Noetzel, MJ, 1992) |
| "We describe two patients in whom clonazepam withdrawal status epilepticus occurred in spite of therapeutic levels of carbamazepine in plasma and cerebrospinal fluid." | 7.67 | Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus. ( Rosati, G; Sechi, GP; Zoroddu, G, 1984) |
| "Oxcarbazepine (OXC) is an effective anticonvulsant used for treatment of partial and secondarily generalized seizures." | 5.40 | Use of oxcarbazepine for treatment of refractory status epilepticus. ( Berning, S; Kellinghaus, C; Stögbauer, F, 2014) |
| " Because it was known from the literature that the half-life of midazolam can increase at high dosage, the kinetics of midazolam (MDZ), 1'-hydroxymidazolam, and 4-hydroxymidazolam were assessed at steady state (dosage 1 mg/min) and after stopping treatment." | 5.35 | Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam. ( Bodmer, M; Grignaschi, N; Haschke, M; Krähenbühl, S; Kummer, O; Link, B; Ruegg, S, 2008) |
| "This study evaluated the anticonvulsant and neuroprotective effects of carbamazepine (CBZ), levetiracetam (LEV), and CBZ + LEV adjunctive treatment in convulsive status epilepticus (CSE) rat model." | 4.02 | Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: Inhibition of cholinergic transmission. ( Abdulwahab, UF; Adedokun, KI; Adekomi, AD; Akanji, NO; Olayiwola, G; Osuntokun, OS, 2021) |
| " In this study, we examined the effects of LEV on neuroinflammation and phagocytic microglia in vivo and in vitro and compared the effects of LEV with those of representative antiepileptic drugs valproate (VPA) and carbamazepine (CBZ)." | 3.91 | Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine. ( Ishihara, Y; Itoh, K; Matsuo, T; Oguro, A; Taniguchi, R; Vogel, CFA; Yamazaki, T, 2019) |
| ") gabapentin (GBP), carbamazepine (CBZ) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) on learning and memory, anxiety, and locomotor activity in rats with lithium-pilocarpine-induced status epilepticus (SE)." | 3.83 | Immediate and delayed treatment with gabapentin, carbamazepine and CNQX have almost similar impact on cognitive functions and behavior in the lithium-pilocarpine model in rats. ( Gulec Suyen, G; Isbil-Buyukcoskun, N; Kahveci, N; Ozluk, K; Sengun, E, 2016) |
| " Diazepam produced a dose-dependent protection against 6-Hz seizures in control and pilocarpine mice, both at 2 weeks and 8 weeks after SE, but with a more pronounced increase in potency in post-SE animals at 2 weeks." | 3.81 | Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model. ( Kaminski, RM; Leclercq, K, 2015) |
| "Carbamazepine (CBZ) is the gold standard antiepileptic drug (AED) for focal onset seizures." | 3.80 | Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus. ( Beran, RG; Cordato, DJ; Malkan, A; Patel, V, 2014) |
| " We tested the hypothesis that status epilepticus (SE) or exposure to phenytoin or phenobarbital affects brain expression of the metabolic enzyme CYP2E1." | 3.80 | Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression. ( Boussadia, B; de Bock, F; Ghosh, C; Janigro, D; Marchi, N; Pascussi, JM; Plaud, C; Rousset, MC, 2014) |
| "A novel class of 19 carbamates was synthesized, and their anticonvulsant activity was comparatively evaluated in the rat maximal electroshock (MES) and subcutaneous metrazol (scMet) seizure tests and pilocarpine-induced status epilepticus (SE) model." | 3.78 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. ( Bialer, M; Hen, N; Yagen, B, 2012) |
| "Cell damage and spatial localization deficits are often reported as long-term consequences of pilocarpine-induced status epilepticus." | 3.75 | Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus. ( Cunha, AO; dos Santos, WF; Liberato, JL; Mortari, MR, 2009) |
| " We describe two patients with idiopathic generalized epilepsy in whom nonconvulsive status epilepticus, aggravated by carbamazepine, was misdiagnosed as psychiatric disorder." | 3.73 | Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. ( D'Arcangelo, G; Guerrini, R; Marini, C; Masi, G; Parmeggiani, L, 2005) |
| " Following pilocarpine-induced status epilepticus interrupted after 4h, rats were continuously videorecorded for onset and recurrence of spontaneous convulsive seizures." | 3.73 | Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat. ( Bentivoglio, M; Chakir, A; Fabene, PF; Ouazzani, R, 2006) |
| "We investigated the effects of valproate (VPA) on an in vivo model of status epilepticus (SE) induced by intrahippocampal application of 4-aminopyridine (4-AP)." | 3.72 | Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. ( Martín, ED; Pozo, MA, 2003) |
| "We report a 14-year-old girl with carbamazepine intoxication who developed alpha coma and status epilepticus." | 3.71 | [A case of carbamazepine intoxication with alpha coma and status epilepticus]. ( Komatsu, K; Ono, A; Sawaishi, Y; Takada, G; Yano, T, 2001) |
| "We report two patients who experienced status epilepticus after carbamazepine overdose." | 3.71 | Status epilepticus after massive carbamazepine overdose. ( Carlisle, RD; Spiller, HA, 2002) |
| " It was proposed that the late activity is a model for pharmacoresistant status epilepticus since it was also refractory to phenytoin, carbamazepine, phenobarbital, and midazolam." | 3.70 | Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. ( Dreier, JP; Heinemann, U; Zhang, CL, 1998) |
| "To compare the frequency of seizures and status epilepticus and their response to first-line drugs in patients with idiopathic generalized epilepsies receiving carbamazepine or phenytoin to those receiving other drugs or no treatment." | 3.70 | Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine. ( Osorio, I; Peltzer, JN; Reed, RC, 2000) |
| "The present study compares the efficacy of carbamazepine (20 mg/kg/day) and vigabatrin (250 mg/kg/day) in preventing hippocampal and amygdaloid damage in the perforant pathway stimulation model of status epilepticus in the rat." | 3.69 | Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala. ( Halonen, T; Pitkänen, A; Tuunanen, J, 1996) |
| "Effect of adenosinergic agents were investigated in lithium-pilocarpine-induced status epilepticus (SE) in rats." | 3.69 | Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents. ( George, B; Kulkarni, SK, 1997) |
| "We describe an adolescent epileptic patient who presented in nonconvulsive status epilepticus that appeared to be related to treatment with carbamazepine." | 3.68 | Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. ( Callahan, DJ; Noetzel, MJ, 1992) |
| "We describe two patients in whom clonazepam withdrawal status epilepticus occurred in spite of therapeutic levels of carbamazepine in plasma and cerebrospinal fluid." | 3.67 | Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus. ( Rosati, G; Sechi, GP; Zoroddu, G, 1984) |
| "The pathophysiology of pilomotor seizures is discussed and the literature on the subject reviewed." | 2.41 | Status-like recurrent pilomotor seizures: case report and review of the literature. ( Chédru, F; Oubary, P; Roze, E, 2000) |
| " New antiepileptic drugs have improved medical management, and technical and theoretical advances in pharmacokinetics have permitted physicians to design balanced dosing for individual patients." | 2.36 | Recent developments in the diagnosis and therapy of epilepsy. ( Crandall, PH; Engel, J; Sterman, MB; Troupin, AS; Wasterlain, CG, 1982) |
| "Oxcarbazepine (OXC) is an effective anticonvulsant used for treatment of partial and secondarily generalized seizures." | 1.40 | Use of oxcarbazepine for treatment of refractory status epilepticus. ( Berning, S; Kellinghaus, C; Stögbauer, F, 2014) |
| "Phenytoin was used in 56 patients (22%) with the majority (n= 43) receiving intravenous phenytoin." | 1.38 | Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change? ( Bergin, P; Jones, P; Rosemergy, I; Walker, E, 2012) |
| "Absence status was aggravated with carbamazepine and generalised tonic-clonic seizures were not controlled with ethosuximide." | 1.36 | Unilateral continuous subclinical paroxysmal activity: an unusual finding in a patient with recurrent absence status. ( Genton, P; Velizarova, R, 2010) |
| " Because it was known from the literature that the half-life of midazolam can increase at high dosage, the kinetics of midazolam (MDZ), 1'-hydroxymidazolam, and 4-hydroxymidazolam were assessed at steady state (dosage 1 mg/min) and after stopping treatment." | 1.35 | Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam. ( Bodmer, M; Grignaschi, N; Haschke, M; Krähenbühl, S; Kummer, O; Link, B; Ruegg, S, 2008) |
| "The correct diagnosis proved to be juvenile absence epilepsy (JAE) in six patients, juvenile myoclonic epilepsy (JME) in four, epilepsy with grand mal on awakening (EGMA) in two and childhood absence epilepsy (CAE) in two." | 1.33 | Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. ( Genton, P; Thomas, P; Valton, L, 2006) |
| "We report on a 38-year-old woman with MELAS presenting with multifocal CPSE and periodic lateralized epileptiform discharges (PLEDs) on EEG during her first strokelike episode." | 1.33 | "Erratic" complex partial status epilepticus as a presenting feature of MELAS. ( Corda, D; Deiana, GA; Rosati, G; Sechi, G, 2006) |
| " The number or dosage of AEDs were more often increased in pregnancies with seizures (OR: 3." | 1.33 | Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. ( , 2006) |
| "We report on a 50-year-old man with mental retardation and right-sided hemi-paresis." | 1.32 | [Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient]. ( Huber, B; Seidel, M; Tomka-Hoffmeister, M, 2004) |
| "Non-convulsive status epilepticus is probably commoner than previously thought, and should be considered as a possible diagnosis in all patients presenting with prolonged episodes of altered consciousness even without other manifestations of epilepsy." | 1.29 | Non-convulsive status epilepticus presenting as a psychiatric condition. ( Cockerell, OC; Sander, JW; Walker, MC, 1996) |
| "Only when the epilepsy is uncontrolled despite high plasma concentrations which cannot be raised because of side effects, a second drug should be given." | 1.27 | [Pharmacotherapy of epilepsy--current problems and controversies]. ( Schmidt, D, 1983) |
| "Children with seizure disorders frequently are treated with anticonvulsant medications such as clonazepam, valproic acid, carbamazepine, and ethosuximide, which cannot be given parenterally." | 1.27 | Rectal anticonvulsants in pediatric practice. ( Laney, SM; Woody, RC, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (24.24) | 18.7374 |
| 1990's | 12 (18.18) | 18.2507 |
| 2000's | 18 (27.27) | 29.6817 |
| 2010's | 18 (27.27) | 24.3611 |
| 2020's | 2 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Hen, N | 1 |
| Bialer, M | 1 |
| Yagen, B | 1 |
| Ueno, T | 1 |
| Katagai, A | 1 |
| Okudera, R | 1 |
| Fujita, M | 1 |
| Tomiyama, M | 1 |
| Osuntokun, OS | 1 |
| Abdulwahab, UF | 1 |
| Akanji, NO | 1 |
| Adedokun, KI | 1 |
| Adekomi, AD | 1 |
| Olayiwola, G | 1 |
| Alam, M | 1 |
| Haq, MAU | 1 |
| Ali, F | 1 |
| Mehwish, H | 1 |
| Nawab, K | 1 |
| Itoh, K | 1 |
| Taniguchi, R | 1 |
| Matsuo, T | 1 |
| Oguro, A | 1 |
| Vogel, CFA | 1 |
| Yamazaki, T | 1 |
| Ishihara, Y | 1 |
| Fanella, M | 1 |
| Egeo, G | 1 |
| Fattouch, J | 1 |
| Casciato, S | 1 |
| Lapenta, L | 1 |
| Morano, A | 1 |
| Giallonardo, AT | 1 |
| Di Bonaventura, C | 1 |
| Kellinghaus, C | 1 |
| Berning, S | 1 |
| Stögbauer, F | 1 |
| Patel, V | 1 |
| Cordato, DJ | 1 |
| Malkan, A | 1 |
| Beran, RG | 1 |
| Subenthiran, S | 1 |
| Abdullah, NR | 1 |
| Muniandy, PK | 1 |
| Joseph, JP | 1 |
| Cheong, KC | 1 |
| Ismail, Z | 1 |
| Mohamed, Z | 1 |
| Boussadia, B | 1 |
| Ghosh, C | 1 |
| Plaud, C | 1 |
| Pascussi, JM | 1 |
| de Bock, F | 1 |
| Rousset, MC | 1 |
| Janigro, D | 1 |
| Marchi, N | 1 |
| Leclercq, K | 1 |
| Kaminski, RM | 1 |
| Dömötör, J | 1 |
| Clemens, B | 1 |
| Gulec Suyen, G | 1 |
| Isbil-Buyukcoskun, N | 1 |
| Kahveci, N | 1 |
| Sengun, E | 1 |
| Ozluk, K | 1 |
| Sperli, F | 1 |
| Placidi, F | 1 |
| Izzi, F | 1 |
| Marciani, MG | 1 |
| Floris, R | 1 |
| Ludovici, A | 1 |
| Cervellino, A | 1 |
| Torelli, F | 1 |
| Romigi, A | 1 |
| Cunha, AO | 1 |
| Mortari, MR | 1 |
| Liberato, JL | 1 |
| dos Santos, WF | 1 |
| Mathew, J | 1 |
| Soman, S | 1 |
| Sadanandan, J | 1 |
| Paulose, CS | 1 |
| Hessen, E | 1 |
| Lossius, MI | 1 |
| Gjerstad, L | 1 |
| Velizarova, R | 1 |
| Genton, P | 2 |
| Ali, A | 1 |
| Dua, Y | 1 |
| Constance, JE | 1 |
| Franklin, MR | 1 |
| Dudek, FE | 1 |
| Rosemergy, I | 1 |
| Bergin, P | 1 |
| Jones, P | 1 |
| Walker, E | 1 |
| Kang, SY | 1 |
| Han, YM | 1 |
| Choi, K | 1 |
| Hwang, SH | 1 |
| Ermolenko, NA | 1 |
| Ermakov, AIu | 1 |
| Buchneva, IA | 1 |
| Zakharova, EI | 1 |
| Kalikina, TA | 1 |
| Trinka, E | 1 |
| Unterberger, I | 1 |
| Spiegel, M | 1 |
| Niedermüller, U | 1 |
| Benke, T | 1 |
| Berger, T | 1 |
| Bauer, G | 1 |
| Martín, ED | 1 |
| Pozo, MA | 1 |
| Tomka-Hoffmeister, M | 1 |
| Huber, B | 1 |
| Seidel, M | 1 |
| Marini, C | 1 |
| Parmeggiani, L | 1 |
| Masi, G | 1 |
| D'Arcangelo, G | 1 |
| Guerrini, R | 1 |
| Corda, D | 1 |
| Rosati, G | 2 |
| Deiana, GA | 1 |
| Sechi, G | 1 |
| Thomas, P | 1 |
| Valton, L | 1 |
| Tucker, A | 1 |
| Miyake, H | 1 |
| Tsuji, M | 1 |
| Ukita, T | 1 |
| Nishihara, K | 1 |
| Chakir, A | 1 |
| Fabene, PF | 1 |
| Ouazzani, R | 1 |
| Bentivoglio, M | 1 |
| Bodmer, M | 1 |
| Link, B | 1 |
| Grignaschi, N | 1 |
| Kummer, O | 1 |
| Ruegg, S | 1 |
| Haschke, M | 1 |
| Krähenbühl, S | 1 |
| Lockard, JS | 1 |
| Levy, RH | 1 |
| Koch, KM | 1 |
| Maris, DO | 1 |
| Friel, PN | 1 |
| Schmidt, D | 1 |
| Mancall, EL | 1 |
| Covington, TR | 1 |
| Alonso, RJ | 1 |
| Sechi, GP | 1 |
| Zoroddu, G | 1 |
| Bittencourt, PR | 1 |
| Richens, A | 1 |
| Johnston, MV | 1 |
| Freeman, JM | 1 |
| Wilbur, R | 1 |
| Kulik, FA | 1 |
| Philbert, A | 1 |
| Dam, M | 1 |
| Engel, J | 1 |
| Troupin, AS | 1 |
| Crandall, PH | 1 |
| Sterman, MB | 1 |
| Wasterlain, CG | 1 |
| Pitkänen, A | 3 |
| Halonen, T | 3 |
| So, EL | 1 |
| Ruggles, KH | 1 |
| Cascino, GD | 1 |
| Ahmann, PA | 1 |
| Weatherford, KW | 1 |
| Ramsay, RE | 1 |
| Lahtinen, H | 1 |
| Ylinen, A | 1 |
| Lukkarinen, U | 1 |
| Sirviö, J | 1 |
| Miettinen, R | 1 |
| Riekkinen, P | 1 |
| Walker, MC | 1 |
| Cockerell, OC | 1 |
| Sander, JW | 1 |
| Tuunanen, J | 1 |
| Löscher, W | 1 |
| Hönack, D | 1 |
| George, B | 1 |
| Kulkarni, SK | 1 |
| Dreier, JP | 1 |
| Zhang, CL | 1 |
| Heinemann, U | 1 |
| Nissinen, J | 1 |
| Roze, E | 1 |
| Oubary, P | 1 |
| Chédru, F | 1 |
| Osorio, I | 1 |
| Reed, RC | 1 |
| Peltzer, JN | 1 |
| Spiller, HA | 2 |
| Carlisle, RD | 2 |
| Ono, A | 1 |
| Yano, T | 1 |
| Sawaishi, Y | 1 |
| Komatsu, K | 1 |
| Takada, G | 1 |
| Brouns, R | 1 |
| Van Paesschen, W | 1 |
| Aucamp, AK | 1 |
| Sharma, P | 1 |
| Gupta, RC | 1 |
| Bhardwaja, B | 1 |
| Mathur, AK | 1 |
| Callahan, DJ | 1 |
| Noetzel, MJ | 1 |
| Fukunishi, I | 1 |
| Kugoh, T | 1 |
| Hosokawa, K | 1 |
| Leppik, IE | 1 |
| Woody, RC | 1 |
| Laney, SM | 1 |
8 reviews available for carbamazepine and Absence Status
| Article | Year |
|---|---|
Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Diagnostic Errors; Epilepsies, Partial; Humans; Male; Myoclon | 2013 |
Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.
Topics: Alcoholism; Anticonvulsants; Carbamazepine; Humans; Hypnotics and Sedatives; Phenytoin; Primidone; S | 1981 |
The epileptic mother and her child.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Breast Feeding; Carbamazepine; Epilepsy; Female; Fetal | 1982 |
Recent developments in the diagnosis and therapy of epilepsy.
Topics: Anticonvulsants; Biofeedback, Psychology; Carbamazepine; Clonazepam; Clorazepate Dipotassium; Condit | 1982 |
Treatment of status epilepticus.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Diazepam; Humans; Phenobarbital; Phenytoin; Status | 1993 |
Status-like recurrent pilomotor seizures: case report and review of the literature.
Topics: Aged; Anticonvulsants; Carbamazepine; Diabetes Complications; Electroencephalography; Humans; Hyperg | 2000 |
The pharmacological treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Clonazepam; Drug Therapy, Combination; Epilepsies, | 1979 |
Status epilepticus.
Topics: Adult; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Humans; Infant, Newborn; Lidoc | 1986 |
1 trial available for carbamazepine and Absence Status
| Article | Year |
|---|---|
Improvement in verbal memory after withdrawal of carbamazepine and valproate in patients with well-controlled epilepsy: a randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Double-Blind Method; Female; Humans; Male; | 2011 |
57 other studies available for carbamazepine and Absence Status
| Article | Year |
|---|---|
Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.
Topics: Animals; Anticonvulsants; Carbamates; Male; Mice; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawle | 2012 |
Carbamazepine-induced convulsive status epilepticus in benign adult familial myoclonic epilepsy: a case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Myoclonic; Humans; Seizur | 2023 |
Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: Inhibition of cholinergic transmission.
Topics: Acetylcholine; Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Hippocampus; Levetir | 2021 |
Dyke-Davidoff-Masson Syndrome: An Unusual Cause of Status Epilepticus and Refractory Seizures.
Topics: Adolescent; Atrophy; Brain; Carbamazepine; Female; Humans; Levetiracetam; Magnetic Resonance Imaging | 2018 |
Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Cells, Cultured; Cytokines; Inflammation; Levetiracetam; Ma | 2019 |
Use of oxcarbazepine for treatment of refractory status epilepticus.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Mal | 2014 |
Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus.
Topics: Administration, Rectal; Adult; Aged; Aged, 80 and over; Anticonvulsants; Benzodiazepines; Carbamazep | 2014 |
G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine.
Topics: Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transpor | 2013 |
Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Brain; Carbamazepine; Cells, Cultured; Central Nervous | 2014 |
Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Levetiracetam; Male; Mice | 2015 |
[FOCAL MOTOR SEIZURES AND STATUS EPILEPTICUS PROVOKED BY MIRTAZAPINE].
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Electroencephalography; Epi | 2015 |
Immediate and delayed treatment with gabapentin, carbamazepine and CNQX have almost similar impact on cognitive functions and behavior in the lithium-pilocarpine model in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amines; Animals; Behavior, Animal; Carbamazepine; Cognition; C | 2016 |
ICTAL aphasia as manifestation of partial status epilepticus in a long-lasting misdiagnosed symptomatic epilepsy: an emblematic case.
Topics: Anticonvulsants; Aphasia; Brain; Carbamazepine; Electroencephalography; Humans; Lorazepam; Magnetic | 2009 |
Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
Topics: Animals; Anticonvulsants; Carbamazepine; Dentate Gyrus; Diazepam; Drug Administration Schedule; Glia | 2009 |
Decreased GABA receptor in the striatum and spatial recognition memory deficit in epileptic rats: effect of Bacopa monnieri and bacoside-A.
Topics: Animals; Anticonvulsants; Bacopa; Basal Ganglia; Behavior, Animal; Bicuculline; Binding, Competitive | 2010 |
Unilateral continuous subclinical paroxysmal activity: an unusual finding in a patient with recurrent absence status.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Diagnosis, Differential; Dose-Response Relationship, D | 2010 |
A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; E | 2012 |
Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Disease Management; Emer | 2012 |
Neurological picture. Transient high-intensity signal of heterotopia on DWI in an epilepsy patient.
Topics: Anticonvulsants; Brain; Carbamazepine; Choristoma; Consciousness Disorders; Diagnosis, Differential; | 2012 |
[Epilepsies with electric status epilepticus in sleep: peculiarities of clinical course and rational approaches to treatment].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Electricity; E | 2011 |
De novo aphasic status epilepticus as presenting symptom of multiple sclerosis.
Topics: Adolescent; Aphasia; Apraxias; Carbamazepine; Cerebral Cortex; Diagnosis, Differential; Electroencep | 2002 |
Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region.
Topics: 4-Aminopyridine; Animals; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; E | 2003 |
[Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient].
Topics: Anticonvulsants; Carbamazepine; Dementia; Electroencephalography; Epilepsy; Humans; Intellectual Dis | 2004 |
Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Depressive Disorder; Diagnosis, Differential; Dia | 2005 |
Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Femal | 2006 |
"Erratic" complex partial status epilepticus as a presenting feature of MELAS.
Topics: Adult; Anticonvulsants; Carbamazepine; Diazepam; Electroencephalography; Female; Humans; MELAS Syndr | 2006 |
Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Electroencephalogra | 2006 |
Transient occipitotemporal subcortical diffusion-weighted magnetic resonance imaging abnormalities associated with status epilepticus. Case report.
Topics: Adult; Carbamazepine; Diazepam; Diffusion Magnetic Resonance Imaging; Drug Administration Schedule; | 2006 |
Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Topics: Animals; Anticonvulsants; Brain Damage, Chronic; Carbamazepine; Convulsants; Disease Models, Animal; | 2006 |
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; | 2008 |
A monkey model for status epilepticus: carbamazepine and valproate compared to three standard anticonvulsants.
Topics: Aluminum Hydroxide; Animals; Anticonvulsants; Carbamazepine; Diazepam; Macaca mulatta; Male; Phenoba | 1983 |
Drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Humans; Phenobarbital; Phenytoin; Statu | 1983 |
[Pharmacotherapy of epilepsy--current problems and controversies].
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Epilepsy, | 1983 |
Pharmacologic therapy of seizures in the elderly.
Topics: Aged; Anticonvulsants; Carbamazepine; Humans; Phenobarbital; Phenytoin; Primidone; Seizures; Status | 1984 |
Failure of carbamazepine to prevent clonazepam withdrawal status epilepticus.
Topics: Adult; Benzodiazepinones; Carbamazepine; Clonazepam; Humans; Male; Status Epilepticus; Substance Wit | 1984 |
Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Benzodiazepinones; Carbamazepine; Child; Child, Preschool; Chlormethiazole; Clona | 1981 |
Pharmacologic advances in seizure control.
Topics: Anticonvulsants; Carbamazepine; Child; Clonazepam; Humans; Kinetics; Phenytoin; Seizures; Status Epi | 1981 |
Prevention of neuronal cell death by anticonvulsants in experimental epilepsy (extended abstract).
Topics: Amygdala; Animals; Anticonvulsants; Brain; Carbamazepine; Cell Survival; Disease Models, Animal; gam | 1995 |
Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide.
Topics: Adult; Age of Onset; Carbamazepine; Female; Humans; Male; Middle Aged; Phenytoin; Seizures; Status E | 1994 |
Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus.
Topics: Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Electric Stimulation; Male; Rats; Rats, W | 1996 |
Non-convulsive status epilepticus presenting as a psychiatric condition.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Diagnostic Errors; Humans; Male; Mental Disorders; Statu | 1996 |
Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Electric Stimulation; gamma-Aminobutyric Acid; Hi | 1996 |
Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Carbamazepine; Cyclodextrins; Diseas | 1997 |
Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents.
Topics: 2-Chloroadenosine; Adenosine; Animals; Anticonvulsants; Carbamazepine; Dipyridamole; Disease Models, | 1997 |
Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development.
Topics: Animals; Anticonvulsants; Carbamazepine; Culture Techniques; Dose-Response Relationship, Drug; Drug | 1998 |
Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat.
Topics: Acetamides; Animals; Anticonvulsants; Body Temperature; Brain; Carbamazepine; Electric Stimulation; | 1999 |
Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Child; Dose-Res | 2000 |
Timely antemortem and postmortem concentrations in a fatal carbamazepine overdose.
Topics: Absorption; Adult; Amobarbital; Anticonvulsants; Carbamazepine; Drug Overdose; Fatal Outcome; Female | 2001 |
[A case of carbamazepine intoxication with alpha coma and status epilepticus].
Topics: Adolescent; Carbamazepine; Charcoal; Coma; Electroencephalography; Female; Gastric Lavage; Humans; M | 2001 |
Status epilepticus after massive carbamazepine overdose.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Drug Overdose; Fatal Outcome; Female; Humans; Hypnotics | 2002 |
Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response | 2002 |
Drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diazepam; Epilepsy; Ethosuximide; Humans; Phenobarbital; | 1979 |
Status epilepticus and death following acute carbamazepine poisoning.
Topics: Adult; Carbamazepine; Female; Humans; Status Epilepticus | 1992 |
Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities.
Topics: Carbamazepine; Child; Electroencephalography; Epilepsy, Absence; Epilepsy, Complex Partial; Female; | 1992 |
Electroclinical correlation examined by simultaneous VTR-EEG monitoring in a patient with complex partial status epilepticus.
Topics: Arousal; Carbamazepine; Child; Electroencephalography; Epilepsy, Temporal Lobe; Evoked Potentials; H | 1989 |
Drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Humans; Phenytoin; Status | 1986 |
Rectal anticonvulsants in pediatric practice.
Topics: Administration, Rectal; Adolescent; Anticonvulsants; Benzodiazepines; Carbamazepine; Child, Preschoo | 1988 |